2012 VEITHsymposium: An Alternative for AAA Repair
The Particulars: Alternatives to open surgery for abdominal aortic aneurysms (AAAs) are needed...
Read More
Author: PWeekly
2012 VEITHsymposium: Competing Treatments for Carotid Artery Disease
Exploring Best Medical Treatments vs. an Intervention The continuing debate among vascular...
Read More
2012 VEITHsymposium: Advances in Lower Extremity Arterial Disease
Safety and Outcomes Using New Endovascular Technologies Chronic total obstruction (CTO) of the...
Read More
2012 VEITHsymposium: Comparing Dressing Materials for Donor-Site Wounds
The Particulars: The optimal dressing material for patients with donor-site wounds (DSWs) after...
Read More
2012 VEITHsymposium: Call To Action by Chairman of VEITHsymposium: Treatment of Pulmonary Embolism On The Horizon, Newer Interventions Show Promise
Endovascular treatment of pulmonary embolism, (PE) a relatively new approach built upon a widely...
Read More
2012 VEITHsymposium
New research is being presented at the 2012 VEITHsymposium, the 39th annual symposium on vascular...
Read More
AHA Scientific Sessions 2012: Aspirin Use & Recurrent VTE
The Particulars: Aspirin is commonly prescribed to patients with venous thromboembolism (VTE). The...
Read More
AHA Scientific Sessions 2012: Examining Follow-Up Costs for Angioplasty
The Particulars: In recent years, hospitals have increasingly begun offering angioplasty in house...
Read More
AHA Scientific Sessions 2012: Comparing Revascularization Approaches in Patients With Diabetes & CAD
The Particulars: Few studies have explored outcomes after PCI or CABG among patients with diabetes...
Read More
AHA Scientific Sessions 2012: Can Daily Multivitamins Prevent CVD?
The Particulars: Studies suggest that many patients with cardiovascular disease (CVD) or...
Read More
AHA Scientific Sessions 2012: Experimental Combination Drug Yields Cardiovascular Benefits
The Particulars: Researchers believe that fixed-dose combination therapy for cardiovascular...
Read More
FDA Approves Propel Mini for Chronic Sinusitis
Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and...
Read More
FDA Approves Xeljanz for Rheumatoid Arthritis
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with...
Read More
AHA Scientific Sessions 2012
New research is being presented at the AHA Scientific Sessions 2012—the American Heart...
Read More
FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots
The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to...
Read More
2012 VEITHsymposium: Meritorious Highlights, Trial Results, and Insight
Innovative Questions in Vascular Surgery Addressed at the 39th Annual VEITHsymposium In New York....
Read More
FDA Approves Synribo for Chronic Myelogenous Leukemia
The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat...
Read More
TCT 2012: Stent With Mesh Covering Achieves Positive Outcomes
The Particulars: Covered stents have been studied for use in embolic protection, but their tightly...
Read More
TCT 2012: PFO Closure Device Superior to Medical Management in Repeat Stroke Prevention
The Particulars: It has been estimated that patent foramen ovale rates are three times higher in...
Read More
TCT 2012: TAVR Successful in a Real-World Setting
The Particulars: Previous research indicates that favorable results can be achieved with...
Read More